Modelling cerebellar pathology of Ataxia-Telangiectasia: Assessing ATM-deficient mice versus human iPS cells

共济失调毛细血管扩张症的小脑病理学建模:评估 ATM 缺陷小鼠与人类 iPS 细胞

基本信息

项目摘要

Ataxia-telangiectasia (A-T) is caused by mutations in the ataxia-telangiectasia mutated (ATM) gene, which manifest in an autosomal recessive multi-system disorder, including neurological dysfunction. The best-studied function of ATM is a master controller of signal transduction for DNA damage response. However, additional and thus far poorly understood functions of ATM likely play critical roles in the neurodegenerative phenotype of A-T. Understanding the molecular basis of many diseases, including A-T, has been hampered by the lack of appropriate in vivo (animal) and in vitro (cell culture) models that accurately reflect the disease phenotypes. Importantly, reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) followed by generation of disease-relevant cell types in vitro provides an opportunity to gain insight into the molecular and cellular basis of disease. Neurological disorders in particular can greatly benefit from iPSC-disease modeling, because cell types of the central nervous system, such as neurons, are typically available only from post-mortem samples.In this project the two applicants build upon their complementary expertise (1) in mouse brain OMICS-level analysis of ataxia pathways affecting Purkinje neuron function and (2) in advanced genetic engineering of iPSCs. The aim of this project is to gain detailed insight into the cellular pathways affecting the neurodegenerative phenotype associated with A-T.Organotypic slice cultures established from Atm-/- mice will be employed to address DNA- and oxidative damage-induced cellular neuroinflammation and autophagy changes, as well as synaptic functions of ATM. Furthermore, transcriptome and proteome analyses of cerebellar samples of Atm-/- and wild-type mice will enable us to discover and annotate novel pathways and markers associated with neuronal functions of ATM in an unbiased manner. In parallel, isogenic pairs of patient-derived iPSC lines and their genetically corrected counterparts will be established for modeling A-T. The isogenic pairs of cell lines will be used to derive neuronal progenitors and characterized in vitro. The output of this project will provide valuable insights into the pathway mechanisms of disease, and cell-based models to investigate A-T-associated neurodegeneration, which may provide novel targets for future therapies.
共济失调-毛细血管扩张症(A-T)是由共济失调-毛细血管扩张症突变(ATM)基因突变引起的,表现为常染色体隐性遗传性多系统疾病,包括神经功能障碍。ATM被研究得最多的功能是DNA损伤反应的信号转导的主控制器。然而,ATM的额外功能可能在A-T的神经退行性表型中发挥关键作用,但迄今为止人们对此知之甚少。由于缺乏合适的体内(动物)和体外(细胞培养)模型来准确反映疾病的表型,许多疾病的分子基础,包括A-T,一直受到阻碍。重要的是,将体细胞重新编程为诱导多能干细胞(IPSCs),然后在体外产生与疾病相关的细胞类型,为深入了解疾病的分子和细胞基础提供了机会。神经障碍尤其可以从IPSC疾病建模中受益匪浅,因为中枢神经系统的细胞类型,如神经元,通常只能从死后样本中获得。在这个项目中,两位申请者建立在他们互补的专业知识基础上(1)在小鼠大脑OMICS水平上分析影响浦肯野神经元功能的共济失调通路,(2)在IPSCs的高级基因工程方面。这个项目的目的是深入了解影响与A-T相关的神经退行性表型的细胞通路。从ATM-/-小鼠建立的器官类型切片培养将被用于研究DNA和氧化损伤诱导的细胞神经炎症和自噬变化,以及ATM的突触功能。此外,对ATM-/-和野生型小鼠小脑样本的转录组和蛋白质组分析将使我们能够以公正的方式发现和注释与ATM神经功能相关的新途径和标记。同时,将建立患者来源的IPSC系及其经过基因校正的对应物的等基因对,用于模拟A-T。这些同基因的细胞系将被用来衍生神经前体细胞,并在体外进行鉴定。该项目的成果将为疾病的通路机制提供有价值的见解,并为研究A-T相关的神经变性提供基于细胞的模型,这可能为未来的治疗提供新的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Georg Auburger其他文献

Professor Dr. Georg Auburger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Georg Auburger', 18)}}的其他基金

Die Wirkung von normalem und pathologischem Ataxin-2 auf die Regulierung der Proteinsynthese in Neuronen
正常和病理ataxin-2对神经元蛋白质合成调节的影响
  • 批准号:
    200750409
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Die Wirkung von Ataxin-2-Defizienz bzw. -Überexpression auf mRNA-3'-Prozessierung und stress granules in Hefe, Maus und Mensch
ataxin-2 缺乏或过度表达对酵母、小鼠和人类 mRNA 3 加工和应激颗粒的影响
  • 批准号:
    186801903
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Atxn2-CAG100-Knock-In Model for Spinocerebellar Ataxia Type 2
Atxn2-CAG100-2 型脊髓小脑共济失调敲入模型
  • 批准号:
    100820481
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
    Research Grants
The Park6 from of idiopathic Parkinson`s disease: Characterization of patients, their cells, and functional role of Pink1 kinase
特发性帕金森病的 Park6:患者及其细胞的特征以及 Pink1 激酶的功能作用
  • 批准号:
    5446392
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Charakterisierung spezifischer Interaktionspartner von Ataxin-2
ataxin-2 特定相互作用伙伴的表征
  • 批准号:
    5423467
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Reversibility of SCA2/ALS13: Contribution of cell types, in conditional mice
SCA2/ALS13 的可逆性:条件小鼠中细胞类型的贡献
  • 批准号:
    467585255
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似国自然基金

小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
  • 批准号:
    82371248
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目

相似海外基金

Generalized prediction errors in the human cerebellum
人类小脑的广义预测误差
  • 批准号:
    10715334
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Control of movements by the cerebellum
小脑对运动的控制
  • 批准号:
    10585632
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Deciphering a novel kinase function for adck2 in the heart
破译心脏中 adck2 的新激酶功能
  • 批准号:
    10664070
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Microstructural Injury to the Brainstem and Spinal Cord Determines Outcomes in CM and SM
脑干和脊髓的微结构损伤决定 CM 和 SM 的结果
  • 批准号:
    10629123
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Redefining Chiari Type I Malformation and its Impact on Brain Development
重新定义 Chiari I 型畸形及其对大脑发育的影响
  • 批准号:
    10629116
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Redefining Chiari Type I Malformation through Genetically, Radiologically, and Clinically-Derived Endophenotypes that are Predictive of Long-Term Neurological Outcome
通过遗传、放射学和临床衍生的可预测长期神经系统结果的内表型重新定义 Chiari I 型畸形
  • 批准号:
    10629124
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
  • 批准号:
    10799992
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
  • 批准号:
    10740682
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Functional Connectivity, Brain Development, and Outcomes in Chiari Type I Malformation
Chiari I 型畸形的功能连接、大脑发育和结果
  • 批准号:
    10629122
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Genetic Underpinnings of CM and SM and Effect on Brain Development
CM 和 SM 的遗传基础及其对大脑发育的影响
  • 批准号:
    10629121
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了